DVN vs FANG vs OXY
161 measures in 16 categories, one definition each, computed from filings and market data.
DVN54.3
Devon Energy Corporation
Energy · Oil & Gas Exploration & Production
$50.73 +3.03%$55.8B mkt cap
Score DNA
FANG49.7
Diamondback Energy, Inc.
Energy · Oil & Gas Exploration & Production
$203.95 +4.27%$57.1B mkt cap
Score DNA
OXY68.5
Occidental Petroleum Corporation
Energy · Oil & Gas Exploration & Production
$62.38 +2.84%$62.4B mkt cap
Score DNA
Price, rebased to 100 three years ago
DVN FANG OXY · weekly adjusted closesSmart money 8Valuation 16Profitability (TTM) 12Returns on capital 11Growth 17Margin history & stability 7Liquidity (latest quarter) 7Leverage & solvency (latest quarter) 13Efficiency 11Cash flow & earnings quality 7Dividends & buybacks 9Scores & forensic checks 15Per share 7Size (TTM) 8Price performance 9Technicals 4
● marks the highest or lowest value where that direction is plainly stronger (margins, returns, coverage, leverage); multiples and yields are left unmarked. Bars show each stock's percentile within its own industry. n/a: the measure does not apply to lenders and insurers.
Smart money
8 measures| Measure | DVN | FANG | OXY |
|---|---|---|---|
| Insider open-market buys, 180d | 1 | 0 | 1 |
| Insider $ bought, 180d | $0.20M | — | $0.25M |
| Congress purchases, 180d | 2 | 0 | 0 |
| Last Congress purchase | 2026-04-09 | — | — |
| 13F net change in holders | +209 | −2 | −61 |
| ETFs adding shares, 30d | 1,037 | 1,178 | 929 |
| ETFs trimming, 30d | 860 | 735 | 604 |
| Net ETF funds, 30d | +177 | +443 | +325 |
Valuation
16 measures| Measure | DVN | FANG | OXY |
|---|---|---|---|
| P/E (TTM) | 17.0x
76th
|
36.0x
91st
|
8.6x
24th
|
| PEG (P/E ÷ 3-yr EPS CAGR) | — | — | 15.89 |
| Price / sales | 2.8x
72nd
|
3.3x
81st
|
2.5x
66th
|
| Price / book | 1.3x
39th
|
1.5x
57th
|
1.5x
52nd
|
| Price / tangible book | 0.9x
15th
|
1.3x
48th
|
1.2x
43rd
|
| Price / free cash flow | 32.6x
92nd
|
8.8x
35th
|
11.7x
59th
|
| Price / operating cash flow | 6.5x
80th
|
5.6x
65th
|
5.7x
70th
|
| Enterprise value | $66.5B
91st
|
$69.3B
94th
|
$72.8B
96th
|
| EV / sales | 3.4x
77th
|
4.0x
81st
|
2.9x
60th
|
| EV / EBITDA | 7.5x
66th
|
9.7x
75th
|
5.2x
34th
|
| EV / EBIT | 14.0x
73rd
|
37.1x
94th
|
11.5x
67th
|
| EV / free cash flow | 38.8x
89th
|
10.7x
43rd
|
13.7x
57th
|
| Earnings yield | 5.9%
45th
|
2.8%
34th
|
11.6%
83rd
|
| FCF yield | 3.1%
28th
|
11.4%
72nd
|
8.5%
53rd
|
| Operating cash flow yield | 15.4%
21st
|
17.8%
36th
|
17.6%
32nd
|
| Graham number (per share) | $59.05
59th
|
$130.78
85th
|
$81.55
79th
|
Profitability (TTM)
12 measures| Measure | DVN | FANG | OXY |
|---|---|---|---|
| Gross margin | 34.0%
23rd
|
44.5%
43rd
|
43.4%
40th
|
| EBITDA margin | 45.1%
45th
|
41.7%
36th
|
55.5%
62nd
|
| Operating margin | 23.5%
49th
|
27.7%
60th
|
23.0%
45th
|
| EBIT margin | 24.2%
45th
|
10.9%
36th
|
25.1%
49th
|
| Net margin | 16.7%
45th
|
9.3%
30th
|
28.8%
85th
|
| NOPAT margin | 18.4%
45th
|
22.7%
57th
|
16.9%
43rd
|
| FCF margin | 8.7%
30th
|
38.0%
81st
|
21.1%
53rd
|
| Operating cash flow margin | 43.9%
36th
|
59.3%
77th
|
43.6%
34th
|
| R&D / revenue | 0.0%
0th
|
0.0%
0th
|
0.0%
0th
|
| SG&A / revenue | 2.2%
9th
|
1.7%
4th
|
4.1%
32nd
|
| Stock comp / revenue | 0.6%
36th
|
0.1%
19th
|
0.0%
0th
|
| Effective tax rate | 21.9%
76th
|
18.0%
26th
|
26.6%
89th
|
Returns on capital
11 measures| Measure | DVN | FANG | OXY |
|---|---|---|---|
| ROE (on average equity) | 11.5%
39th
|
4.1%
28th
|
18.7%
70th
|
| ROA | 6.4%
40th
|
2.2%
30th
|
8.8%
68th
|
| ROIC | 6.9%
28th
|
7.8%
38th
|
8.1%
40th
|
| ROCE | 7.4%
38th
|
2.9%
32nd
|
8.7%
43rd
|
| Return on tangible assets | 9.3%
49th
|
2.6%
32nd
|
7.7%
40th
|
| Cash ROIC (OCF / invested capital) | 16.4%
19th
|
20.3%
38th
|
21.0%
43rd
|
| Gross profitability (GP / assets) | 9.3%
9th
|
10.8%
17th
|
13.6%
34th
|
| ROIC, 3-yr average | 10.5%
64th
|
8.5%
50th
|
5.5%
30th
|
| ROIC, 5-yr average | 20.0%
62nd
|
12.7%
38th
|
9.7%
31st
|
| ROE, 5-yr average | 30.0%
82nd
|
17.0%
38th
|
20.2%
46th
|
| Incremental ROIC | 4.7%
39th
|
-21.0%
20th
|
-71.4%
15th
|
Growth
17 measures| Measure | DVN | FANG | OXY |
|---|---|---|---|
| Revenue growth (TTM YoY) | 17.0%
57th
|
22.0%
70th
|
-7.5%
11th
|
| Revenue growth (QoQ) | 94.8%
94th
|
31.2%
62nd
|
59.2%
89th
|
| Revenue CAGR, 3 yr | 5.3%
57th
|
27.2%
88th
|
-7.1%
14th
|
| Revenue CAGR, 5 yr | 19.3%
49th
|
31.5%
77th
|
4.9%
3rd
|
| Gross profit CAGR, 3 yr | 0.5%
57th
|
13.6%
79th
|
-4.6%
43rd
|
| Operating income CAGR, 3 yr | -8.8%
61st
|
-1.1%
76th
|
-14.2%
51st
|
| Net income growth (TTM YoY) | 15.3%
35th
|
-58.7%
0th
|
206.7%
87th
|
| Net income CAGR, 3 yr | -11.8%
52nd
|
-22.9%
24th
|
2.4%
86th
|
| EPS growth (TTM YoY) | -22.0%
16th
|
-57.1%
0th
|
206.2%
87th
|
| EPS CAGR, 3 yr | -22.4%
41st
|
-33.5%
10th
|
0.5%
93rd
|
| EPS CAGR, 5 yr | 53.8%
77th
|
— | — |
| FCF growth (TTM YoY) | — | — | 10.7%
33rd
|
| FCF CAGR, 3 yr | 17.3%
73rd
|
56.8%
97th
|
-14.9%
20th
|
| Operating cash flow CAGR, 3 yr | 6.6%
60th
|
17.2%
81st
|
-8.2%
19th
|
| Book value CAGR, 3 yr | 37.1%
95th
|
16.1%
83rd
|
10.7%
63rd
|
| Dividend CAGR, 3 yr | -8.7%
38th
|
-9.4%
34th
|
0.9%
75th
|
| Sustainable growth rate | 8.7%
35th
|
0.3%
15th
|
14.5%
68th
|
Margin history & stability
7 measures| Measure | DVN | FANG | OXY |
|---|---|---|---|
| Gross margin, 3-yr average | 30.3%
16th
|
46.5%
50th
|
37.8%
32nd
|
| Operating margin, 3-yr average | 24.9%
43rd
|
38.3%
82nd
|
21.9%
34th
|
| Net margin, 3-yr average | 19.0%
57th
|
24.8%
75th
|
18.0%
55th
|
| FCF margin, 3-yr average | 8.3%
34th
|
0.1%
18th
|
17.9%
55th
|
| Revenue stability (0-1) | 0.82
66th
|
0.95
82nd
|
0.16
20th
|
| Earnings stability (0-1) | 0.04
20th
|
0.14
50th
|
0.10
43rd
|
| Margin stability (0-1) | 0.82
59th
|
0.83
64th
|
0.67
20th
|
Liquidity (latest quarter)
7 measures| Measure | DVN | FANG | OXY |
|---|---|---|---|
| Cash & short-term investments | $1.0B
89th
|
$462.0M
74th
|
$4.2B
94th
|
| Net cash (− = net debt) | −$10.7B
4th
|
−$12.2B
2nd
|
−$10.5B
6th
|
| Working capital | −$2.0B
2nd
|
−$3.0B
0th
|
$3.2B
96th
|
| Current ratio | 0.72
38th
|
0.47
9th
|
1.41
79th
|
| Quick ratio | 0.67
34th
|
0.45
13th
|
1.13
68th
|
| Cash ratio (cash + ST investments / current liabilities) | 0.14
34th
|
0.08
28th
|
0.53
70th
|
| Defensive interval (days) | 763 days
77th
|
304 days
34th
|
584 days
68th
|
Leverage & solvency (latest quarter)
13 measures| Measure | DVN | FANG | OXY |
|---|---|---|---|
| Total debt | $11.7B
91st
|
$12.6B
94th
|
$14.6B
98th
|
| Debt / equity | 0.28
30th
|
0.33
33rd
|
0.35
35th
|
| Net debt / equity | 0.26
33rd
|
0.32
39th
|
0.25
30th
|
| Debt / assets | 16.6%
26th
|
18.0%
32nd
|
18.2%
34th
|
| Debt / capital | 22.0%
30th
|
25.0%
33rd
|
25.9%
35th
|
| Debt / EBITDA | 1.33
43rd
|
1.77
52nd
|
1.05
36th
|
| Net debt / EBITDA | 1.22
43rd
|
1.71
59th
|
0.75
30th
|
| Interest coverage (EBIT / interest) | 9.3x
67th
|
7.0x
60th
|
7.5x
62nd
|
| Cash interest coverage | 16.8x
70th
|
38.0x
87th
|
13.0x
54th
|
| Debt payback (years of OCF) | 1.4 yrs
50th
|
1.2 yrs
43rd
|
1.3 yrs
48th
|
| Liabilities / assets | 41.1%
36th
|
37.4%
21st
|
47.3%
51st
|
| IS credit model rating | BBB | A- | A |
| Implied credit spread (bps) | 275
47th
|
175
38th
|
150
32nd
|
Efficiency
11 measures| Measure | DVN | FANG | OXY |
|---|---|---|---|
| Asset turnover | 0.38
43rd
|
0.24
9th
|
0.31
26th
|
| Fixed asset turnover | 0.31
22nd
|
0.26
7th
|
0.19
2nd
|
| Inventory turnover | 38.0
67th
|
104.4
90th
|
7.0
14th
|
| Receivables turnover | 7.9
34th
|
10.7
62nd
|
7.6
30th
|
| Days sales outstanding | 46 days
66th
|
34 days
38th
|
48 days
70th
|
| Days inventory outstanding | 10 days
33rd
|
3 days
10th
|
52 days
86th
|
| Days payables outstanding | 35 days
32nd
|
28 days
21st
|
95 days
70th
|
| Cash conversion cycle (days) | 21 days
83rd
|
9 days
66th
|
5 days
60th
|
| Capex / revenue | 35.1%
65th
|
21.3%
35th
|
22.5%
39th
|
| Capex / depreciation | 1.68
85th
|
0.69
28th
|
0.74
35th
|
| Operating expense ratio | 21.5%
40th
|
0.0%
0th
|
35.6%
68th
|
Cash flow & earnings quality
7 measures| Measure | DVN | FANG | OXY |
|---|---|---|---|
| Operating cash flow / net income | 2.62
65th
|
6.40
97th
|
1.51
18th
|
| FCF / net income | 0.52
24th
|
4.10
94th
|
0.73
32nd
|
| FCF / operating cash flow | 19.9%
27th
|
64.1%
77th
|
48.4%
59th
|
| Capex / operating cash flow | 80.1%
73rd
|
35.9%
24th
|
51.6%
42nd
|
| Accruals ratio | -10.4%
66th
|
-12.0%
51st
|
-4.5%
87th
|
| Sloan accruals ratio | -13.4%
34th
|
-9.3%
53rd
|
-5.9%
81st
|
| Earnings quality score (0-1) | 0.75
0th
|
0.75
0th
|
1.00
82nd
|
Scores & forensic checks
15 measures| Measure | DVN | FANG | OXY |
|---|---|---|---|
| IS score | 54
43rd
|
50
38th
|
68
66th
|
| IS profitability | 72
62nd
|
59
26th
|
84
81st
|
| IS growth | 63
57th
|
38
20th
|
51
39th
|
| IS value | 83
77th
|
59
36th
|
87
87th
|
| IS momentum | 89
59th
|
68
33rd
|
80
46th
|
| IS risk (safety) | 30
34th
|
30
34th
|
50
62nd
|
| IS quality | 81
49th
|
81
51st
|
88
81st
|
| IS balance sheet | 67
66th
|
59
55th
|
71
77th
|
| IS earnings quality | 63
55th
|
65
60th
|
75
85th
|
| IS cash flow | 46
43rd
|
76
70th
|
66
55th
|
| Piotroski F-score (0-9) | 5
15th
|
7
43rd
|
7
43rd
|
| Altman Z-score | 1.5
43rd
|
1.5
45th
|
1.9
64th
|
| Beneish M-score | −2.43
62nd
|
−2.72
49th
|
−8.07
2nd
|
| Ohlson O-score | −9.55
32nd
|
−9.55
30th
|
−9.70
28th
|
| IS credit score | 56
51st
|
69
62nd
|
73
68th
|
Size (TTM)
8 measures| Measure | DVN | FANG | OXY |
|---|---|---|---|
| Market cap | $55.8B
91st
|
$57.1B
94th
|
$62.4B
96th
|
| Revenue | $19.6B
91st
|
$17.1B
89th
|
$25.2B
94th
|
| EBITDA | $8.8B
91st
|
$7.1B
89th
|
$14.0B
94th
|
| Net income | $3.3B
91st
|
$1.6B
83rd
|
$7.3B
98th
|
| Free cash flow | $1.7B
81st
|
$6.5B
96th
|
$5.3B
94th
|
| Total assets | $70.9B
96th
|
$70.2B
94th
|
$80.4B
98th
|
| Shareholders' equity | $41.7B
98th
|
$37.9B
94th
|
$41.7B
96th
|
| Employees | 2,200
89th
|
1,762
83rd
|
10,412
100th
|
Price performance
9 measures| Measure | DVN | FANG | OXY |
|---|---|---|---|
| 1 day | +3.0% | +4.3% | +2.8% |
| 1 week | +5.1% | +6.2% | +3.8% |
| 1 month | +4.1% | +3.6% | +5.2% |
| 3 months | +16.6% | +4.4% | +13.1% |
| 6 months | +16.3% | +13.1% | +16.0% |
| Year to date | +36.5% | +33.9% | +47.2% |
| 1 year | +59.5% | +44.7% | +49.8% |
| 3 years, cumulative | +19.7% | +40.9% | +2.6% |
| 5 years, cumulative | +61.2% | +125.5% | +96.7% |
Technicals
4 measures| Measure | DVN | FANG | OXY |
|---|---|---|---|
| RSI 14 | 62.0 | 64.4 | 63.7 |
| From 52-week high | −2.4% | −6.0% | −7.5% |
| From 52-week low | +65.3% | +49.9% | +60.8% |
| Beta | 0.43 | 0.41 | 0.16 |
InsiderStreet reports findings from filings and market data. A comparison is not a recommendation to buy or sell either stock.Every figure is computed in code · data as of 2026-10-17